Back to Search
AMY HAYNES, MD
MD
Family Medicine Physician
NPI: 1871543926IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
30349(TN)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
EAST TENNESSEE STATE UNIVERSITY QUILLEN COLLEGE OF MEDICINE
Class of 1996
Research & Publications (20)
Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy.
PMID 19365737·Med Oncol·2010
4-observational
Assigned versus random, countermeasure-like responses in the p300 based complex trial protocol for detection of deception: task demand effects.
PMID 19543970·Appl Psychophysiol Biofeedback·2009
8-other
Identification of the reactive cis,mer isomer of [Ir(CO)2I3Me]-: relation to the mechanism of iridium-catalyzed methanol carbonylation.
PMID 19061388·Inorg Chem·2009
8-other
Transitional cell carcinoma due to chronic UroLume stent irritation.
PMID 19193405·Urology·2009
5-case
Involvement of macroautophagy in the caspase-independent killing of Burkitt lymphoma cell lines by rituximab.
PMID 19183195·Br J Haematol·2009
8-other
A surgical safety checklist to reduce morbidity and mortality in a global population.
PMID 19144931·N Engl J Med·2009
4-observational
Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.
PMID 19344416·Br J Haematol·2009
8-other
A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma.
PMID 18381234·Cancer Treat Rev·2008
1-meta
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
PMID 18838474·Haematologica·2008
8-other
Internalisation of uncross-linked rituximab is not essential for the induction of caspase-independent killing in Burkitt lymphoma cell lines.
PMID 18766972·Leuk Lymphoma·2008
8-other
The use of erythropoiesis-stimulating agents in patients with non-myeloid hematological malignancies: a systematic review.
PMID 18629499·Ann Hematol·2008
1-meta
An estimation of the global volume of surgery: a modelling strategy based on available data.
PMID 18582931·Lancet·2008
8-other
A requirement for calcium in the caspase-independent killing of Burkitt lymphoma cell lines by Rituximab.
PMID 18544085·Br J Haematol·2008
8-other
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.
PMID 18313854·Cancer Treat Rev·2008
1-meta
Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic review.
PMID 18224666·Cancer·2008
1-meta
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma.
PMID 18353164·Br J Haematol·2008
4-observational
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.
PMID 18318762·Br J Haematol·2008
4-observational
A paraneoplastic manifestation of metastatic breast cancer responding to endocrine therapy: a case report.
PMID 19087318·World J Surg Oncol·2008
5-case
Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.
PMID 18454188·Curr Oncol·2008
8-other
Changing cultures: enhancing mental health and wellbeing of refugee young people through education and training.
PMID 18154223·Promot Educ·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 405 SCENIC DR
ROGERSVILLE, TN 37857 - Phone
- (423) 272-2111
Quick Facts
- NPI
- 1871543926
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile